Koers Epirus Biopharmaceuticals Inc Nasdaq
Aandelen
US29428P1075
Biotechnologie & Medisch Onderzoek
Omzet 2014 | 0 0 | Omzet 2015 | 0,7 0,65 | Marktkapitalisatie | 75,33 mln. 70,33 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -41 mln. -38,28 mln. | Nettowinst (verlies) 2015 | -52 mln. -48,55 mln. | EV/omzet 2014 | 14.770.294.750 x |
Nettoliquiditeiten 2014 | 14,18 mln. 13,24 mln. | Nettoliquiditeiten 2015 | 16,68 mln. 15,57 mln. | EV/omzet 2015 | 83.658.631 x |
K/w-verhouding 2014 |
-0,83
x | K/w-verhouding 2015 |
-1,35
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,41% | 45,51 mld. | |
+38,65% | 39,36 mld. | |
-8,62% | 38,52 mld. | |
+26,95% | 30,74 mld. | |
-13,50% | 26,03 mld. | |
+10,74% | 25,92 mld. | |
+44,87% | 14,13 mld. | |
+34,36% | 12,73 mld. | |
-7,14% | 11,29 mld. |